Caris Life Sciences Balance Sheet
NASDAQ: CAIHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Caris Life Sciences financial position
At the end of fiscal 2025, Caris Life Sciences reported total assets of $1.13 billion, up 227.5% from a year earlier against total liabilities of $548.4 million. Shareholders' equity stood at $577.3 million, or 51.3% of assets. The company held $796.3 million in cash and equivalents against $379.0 million of debt, a net cash position of $417.3 million.
The current ratio (current assets divided by current liabilities) was 7.85, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.66.
Summary generated from market data by MetaCap's automated system. Methodology
Caris Life Sciences balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|
| Cash & Equivalents | 796.27M | 63.95M | — |
| Short-Term Investments | 2.29M | 2.20M | — |
| Receivables | 112.14M | 88.24M | — |
| Total Current Assets | 997.80M | 215.73M | — |
| Property, Plant & Equipment | 63.17M | 67.82M | — |
| Goodwill | 19.34M | 19.34M | — |
| Total Assets | 1.13B | 343.73M | — |
| Accounts Payable | 39.21M | 27.79M | — |
| Short-Term Debt | 169.00K | 60.09M | — |
| Total Current Liabilities | 127.14M | 165.42M | — |
| Long-Term Debt | 378.82M | 319.44M | — |
| Total Liabilities | 548.36M | 620.92M | — |
| Shareholders' Equity | 577.31M | -2.50B | -2.14B |
| Retained Earnings | -2.55B | -2.47B | — |
| Total Debt | 378.99M | 379.53M | — |
| Net Cash (Debt) | 419.58M | -313.38M | — |
| Shares Outstanding | 282.53M | 36.50M | — |
This table shows 3 annual periods of Caris Life Sciences's balance sheet, from FY 2025 back to FY 2023, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow CAI's reporting calendar. What is a balance sheet?